Company / Net Debt per Share
Xenon Pharmaceuticals Inc. Net Debt per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.53
FY2019
5-year range
-
FY2017-FY2019
Trend
+81.8%
vs FY2018
Sector context
#59 of 82
Health Care
What the data says
At $-0.53, Xenon Pharmaceuticals Inc.'s net debt per share ranks #24 of 82 in the Health Care sector. Increased from $-0.61 to $-0.53 over the past 2 years.
Based on SEC 10-K filings.
-0.53 in FY2019.
Increased from $-0.61 to $-0.53 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#24 of 82 in Health CareTop 28% of 82This company -$0.53 Sector average $13.70
▼
-103.9% below sector average
Key checks
Key Insights
- In FY2019, net debt per share increased 81.8% year-over-year.
- Ranks #59 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -$0.53 | +81.8% |
| FY2018 | -$2.93 | -378.0% |
| FY2017 | -$0.61 | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026